Abbott to Pay $385 Million to Resolve US Infant Formula Claims

Abbott Laboratories agreed to pay $385 million to settle US allegations over poor manufacturing practices at two facilities, including one tied to an investigation of a contaminated plant that made powder infant formula, according to Bloomberg.